Elutia Inc. (ELUT)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $36.53M
Last updated: Nov 17, 2026 at 4:10 PM ET
Elutia Inc. (ELUT) Statistics
Elutia (ELUT) has a market cap of $36.53M and an enterprise value of $15.54M. It kept 1621.19% of revenue as net income over the last 12 months. It holds $21.00M more cash than debt, 57.47% of its market cap.
Total Valuation
Enterprise value is 57.47% below the market cap, as cash exceeds debt.
| Market Cap | $36.53M |
|---|---|
| Enterprise Value | $15.54M |
| Latest price (Nov 17, 2026) | $0.85 |
Key Dates
The next earnings report is expected on Mar 9, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 9, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 5, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 11.3x and 2.5x.
| P/E Ratio | 0.9x |
|---|---|
| P/S Ratio | 11.3x |
| Forward P/S | 4.9x |
| P/B Ratio | 2.5x |
| P/TBV Ratio | 2.6x |
Enterprise Valuation
| EV / Earnings | 0.3x |
|---|---|
| EV / Sales | 4.6x |
Price Statistics
The stock is up 14.54% over 52 weeks and trades 3.66% above its 50-day average.
| Beta (1Y) | 0.18 |
|---|---|
| 52-Week Change | +14.54% |
| 1-Month Change | +4.75% |
| 3-Month Change | -7.51% |
| 6-Month Change | -23.76% |
| 5-Year Change | -85.57% |
| Total Return (1Y) | +14.54% |
| Total Return (3Y CAGR) | -18.88% |
| Total Return (5Y CAGR) | -32.24% |
| Max Drawdown (1Y) | -39.75% |
| Max Drawdown (3Y) | -89.82% |
| Sharpe Ratio (1Y) | 0.27 |
| Correlation with SPY (1Y) | 0.03 |
| 50-Day Average | $0.82 |
| 200-Day Average | $0.97 |
| 52-Week Range | $0.50 to $1.39 |
| RSI (14 Days) | 52.7 |
| Average Volume (20 Days) | 75.60K |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 2.63x current liabilities, and total debt is 0.53x shareholder equity.
| Current Ratio | 2.63x |
|---|---|
| Quick Ratio | 2.61x |
| Debt / Equity | 0.53x |
Returns and Efficiency
Return on invested capital is -111.14% over the last 12 months, against a 5-year average of 32.51%.
| Return on Equity (ROE) | 354.92% |
|---|---|
| Return on Assets (ROA) | 112.86% |
| Return on Invested Capital (ROIC) | -111.14% |
| ROA (5Y Average) | -47.04% |
| ROIC (5Y Average) | 32.51% |
| Asset Turnover | 0.09x |
| Inventory Turnover | 0.12x |
| Receivables Turnover | 2.31x |
| Cash Conversion Cycle | -2932 days |
Scores
ELUT has an Altman Z-Score of -5.97, in the distress zone below 1.81, and a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | -5.97 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 5 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $3.35M over the last 12 months is down 24.81% from the 12 months before.
| Revenue | $3.35M |
|---|---|
| Revenue Growth (YoY) | -24.81% |
| Gross Profit | $3.18M |
| Operating Income | -$25.11M |
| Pretax Income | -$23.91M |
| Net Income | $54.39M |
| Reported EPS (TTM) | $1.00 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 31.79% of the $48.19M in total assets.
| Cash and Equivalents | $29.09M |
|---|---|
| Total Debt | $8.10M |
| Net Cash | $21.00M |
| Net Cash Per Share | $0.47 |
| Working Capital | $26.14M |
| Shareholder Equity | $15.32M |
| Book Value Per Share | $0.35 |
| Tangible Book Value | $14.61M |
| Tangible Book Per Share | $0.33 |
| Total Assets | $48.19M |
| Total Liabilities | $32.87M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $1.45M of capital spending, operating cash flow left -$50.68M of free cash flow.
| Operating Cash Flow | -$49.23M |
|---|---|
| Capital Expenditures | $1.45M |
| Free Cash Flow | -$50.68M |
| FCF Per Share | -$1.14 |
| Depreciation and Amortization | $1.51M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -748.35%.
| Gross Margin | 94.75% |
|---|---|
| Operating Margin | -748.35% |
| Pretax Margin | -712.76% |
| Net Margin | 1621.19% |
| FCF Margin | -1510.58% |
| Gross Margin (5Y Average) | 46.74% |
| Net Margin (5Y Average) | -56.24% |
Growth
Revenue fell 19.82% a year over 3 years.
| Revenue Growth (3Y CAGR) | -19.82% |
|---|---|
| Revenue Growth (5Y CAGR) | -22.04% |
Dividends and Yields
ELUT does not pay a dividend. Its free cash flow yield is -133.93%.
| Earnings Yield | 111.11% |
|---|---|
| FCF Yield | -133.93% |
| Buyback Yield | -0.20% |
| Shareholder Yield | -0.20% |
Peer Position
Against 12 similar companies, ELUT has the 3rd highest P/S.
P/S RatioPeer median 1.3x
ROICPeer median -41.53%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +9.04%
| P/S Ratio | 11.3x vs 1.3x median |
|---|---|
| ROIC | -111.14% vs -41.53% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | -24.81% vs +9.04% median |
Analyst Forecast
Consensus estimates put revenue growth at -40.86% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | -40.86% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Overvalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About ELUT
What is ELUT's market cap?
Elutia has a market cap of $36.53M. Its enterprise value, which adds debt and subtracts cash, is $15.54M.
What is ELUT's P/E ratio?
Elutia has a trailing P/E ratio of 0.9x.
How many shares of ELUT are outstanding?
Elutia has 44.31M shares outstanding. The count is up 4.44% from a year earlier.
Does ELUT pay a dividend?
No. Elutia does not pay a dividend.
How much debt does ELUT have?
Elutia has $8.10M of total debt and $29.09M of cash and equivalents, a net cash position of $21.00M.
ELUT pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors